Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Resmed Inc banner

Resmed Inc
ASX:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
ASX:RMD
Watchlist
Price on Oct 15: 33.69 AUD
Market Cap: AU$32.9B

Prices of ASX stocks are not being updated. The latest RMD price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.

Write Note Create Alert Ask AI

Intrinsic Value

Is RMD undervalued or overvalued?

See the intrinsic value estimate for Resmed Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RMD Intrinsic Value
LOCKED
Unlock
Today vs. history

RMD looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with RMD’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RMD
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price AU$33.69
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RMD

Fundamental Analysis

What Resmed Does

Health Care

Resmed makes devices and software for people with sleep apnea, COPD, and other breathing disorders. Its main products are CPAP and bilevel machines, masks, and other patient interface products that help people breathe more easily at home while they sleep. It also sells cloud-connected software that helps doctors, sleep clinics, and home medical equipment providers track treatment and manage patients.

Headquarters
United States of America US
Employees
10 600
IPO date
Jun 1, 1995
Read the full company overview
View Company Overview

Resmed has a narrow economic moat

No Moat Narrow Wide

Patents limit direct copying of Resmed’s breathing devices and masks, while its software makes replacing established care systems time-consuming. These protections help it retain customers, although rivals can still compete with different product designs.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Resmed Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

RMD Insider Trading
Buy and sell transactions by insiders

Continue RMD Research

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall St Estimates
RMD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Resmed Inc listings:
NYSE • USD
RMD
 LSE • USD
0KW4
 F • EUR
RME
 F • EUR
RMEA
 OTC • USD
RSMDF
 XMUN • EUR
RME
 SWB • EUR
RME
 SWB • EUR
RMEA
Discover More
What is the Intrinsic Value of one RMD stock?

The intrinsic value for Resmed Inc (RMD) under the Base Case is hidden AUD.

Is RMD stock undervalued or overvalued?

Compared with the last price of 33.69 AUD on Oct 15, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.